Remdesivir: Yay or Nay?
Last updated on
Since our last article on Remdesivir, much has been discovered about its potential clinical application via several high-profile clinical trials. On 15th October 2020, we first heard of less-than-promising results from the WHO SOLIDARITY trial that Remdesivir has “little to no effect on hospitalized COVID-19, as indicated by overall mortality, initiation of ventilation, and duration...
COVAX: No one is safe until everyone is safe (UPDATED)
Last updated on
UPDATED (as of 19th Nov 2020) : Malaysia has decided to pay RM94 million upfront and share guarantee payments upon signing the COVAX facility agreement. This is part of the RM3 billion allocated in Budget 2021 to cover COVID-19 vaccine supply access and development. The Malaysian government has also signed another agreement with the Chinese...
We Answer Common Questions About The D614G Mutation
Last updated on
Nope, D614G is not the latest breed of durians in town. We hate to burst your bubble, but it is a mutation on the original COVID-19 virus. Simply put, SARS-CoV-2 got an upgrade, for better or for worse. Source: Giphy The recent announcement on 16th August by DG Datuk Dr Noor Hisham that the D614G-type...
COVID-19 Vaccine Updates: Latest Worldwide Developments, Malaysia’s Involvement, and Barriers to Vaccine Success
Last updated on
Once upon a time, there was a pandemic called COVID-19. It was evil and contagious, causing the deaths of millions across the globe. Everyone feared it, and we were powerless against it. That is, until Vaccine X came about and we were all saved. Everyone could finally resume their day-to-day routine! This sounds like a...
COVID-19 Treatment Updates: Remdesivir’s Coming To Malaysia, and KKM Releases Latest Treatment Guidelines
Last updated on
Remdesivir in Malaysia As everyone eagerly awaits results from clinical trials regarding treatment and vaccination option(s) for COVID-19, a possible “knight in shining armour” emerges: Remdesivir. Remde-saviour? Currently, the medication is undergoing 6 separate clinical trials for COVID-19: 2 initiated by Gilead (the manufacturer) (moderate & severe manifestations) 2 by health authorities in China (mild/moderate...
